Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CTSA | P10619 | 9/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ACACB | O00763 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8366794 | 0.84 | ALDH1A1 (0.39) | ALDH1A1CTSARAB9ANPC1MAPKAPK2 | |
| Ammonia Solution, Strong SCHEMBL7013057 | 0.83 | CTSA (0.38) | ALDH1A1CTSARAB9ATSHRNPC1 | |
| SCHEMBL31079263 | 0.78 | ALDH1A1 (0.41) | ALDH1A1CTSARAB9AHSD17B10 | |
| SCHEMBL6009362 | 0.78 | RBBP9 (0.49) | ALDH1A1CTSARAB9ATSHRNPC1 | |
| SCHEMBL29291637 | 0.77 | CA12 (0.53) | ALDH1A1CTSATSHR | |
| SCHEMBL2653105 | 0.76 | KDM4E (0.36) | ALDH1A1CTSARAB9AHSD17B10TSHR | |
| SCHEMBL11983388 | 0.76 | ALDH1A1 (0.48) | ALDH1A1CTSATSHRACACBMAPKAPK2 | |
| SCHEMBL3311139 | 0.75 | — | — | |
| SCHEMBL28300435 | 0.74 | FDPS (0.45) | ALDH1A1CTSARAB9ATSHRACACB | |
| SCHEMBL28867928 | 0.74 | LMNA (0.44) | ALDH1A1CTSARAB9AHSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4272831-A2 | DIAZABICYCLOOCTANONES AS INHIBITORS OF SERINE BETA-LACTAMASES | Antabio SAS (FR) | 2023-11-08 | — | — | EP | disclosed |
| CN-108659974-A | A kind of bathroom peculiar-smell-removal detergent of -5- of methyl containing 4- Acetoxyethyls-thiazole | 枣庄九星生物科技有限公司 | 2018-10-16 | — | — | CN | disclosed |
| CN-105713015-B | A kind of imidazoheterocycles azo derivative and its preparation method and application | 华南农业大学 | 2018-07-06 | — | — | CN | disclosed |
| CN-105713015-A | Imidazo heterocyclic azo derivative and preparation method and application thereof | 华南农业大学 | 2016-06-29 | — | — | CN | disclosed |
| EP-1292573-B1 | SUBSTITUTED THIOACETAMIDES | CEPHALON INC (US) | 2010-12-29 | — | — | EP | disclosed |
| EP-2186803-A2 | Substituted thioacetamides | CEPHALON, INC. (US) | 2010-05-19 | — | — | EP | disclosed |
| US-20080027228-A1 | Substituted thioacetamides | CEPHALON, INC. (US) | 2008-01-31 | — | — | US | disclosed |
| US-7268132-B2 | Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder | CEPHALON, INC. (US) | 2007-09-11 | — | — | US | disclosed |
| US-RE39575-E1 | Substituted thioacetamides | CEPHALON, INC. (US) | 2007-04-17 | — | — | US | disclosed |
| US-7022721-B1 | Method and composition for rejuvenating cells, tissues, organs, hair and nails | ULRICH PETER C | 2006-04-04 | — | — | US | disclosed |
| EP-1368029-A4 | METHOD AND COMPOSITION FOR REJUVINATING CELLS, TISSUES, ORGANS, HAIR AND NAILS | FARRINGTON PHARMACEUTICALS LLC (US) | 2006-02-15 | — | — | EP | disclosed |
| US-20050245512-A1 | Method and composition for rejuvinating cells, tissues organs, hair and nails | ULRICH PETER C | 2005-11-03 | — | — | US | disclosed |
| US-6777557-B2 | Method and composition for rejuvenating cells, tissues organs, hair and nails | FARRINGTON PHARMACEUTICALS, LLC | 2004-08-17 | — | — | US | disclosed |
| EP-1368029-A2 | METHOD AND COMPOSITION FOR REJUVINATING CELLS, TISSUES, ORGANS, HAIR AND NAILS | Farrington Pharmaceuticals, LLC (US) | 2003-12-10 | — | — | EP | disclosed |
| US-20020188015-A1 | Method and composition for rejuvinating cells, tissues organs, hair and nails | FARRINGTON PHARMACEUTICALS, LLC | 2002-12-12 | — | — | US | disclosed |
| WO-2002062301-A2 | METHOD AND COMPOSITION FOR REJUVINATING CELLS, TISSUES, ORGANS, HAIR AND NAILS | FARRINGTON PHARMACEUTICALS, LLC (US) | 2002-08-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080027228-A1 | Substituted thioacetamides | TST, TTR, TBCA | ALDH1A1 763/4885CTSA 1708/4885RAB9A 3498/4885 |
| US-20020188015-A1 | Method and composition for rejuvinating cells, tissues organs, hair and nails | TERT, TELO2, HKDC1 | ALDH1A1 3396/4885CTSA 2635/4885RAB9A 1317/4885 |
| US-20050245512-A1 | Method and composition for rejuvinating cells, tissues organs, hair and nails | TERT, TELO2, HKDC1 | ALDH1A1 3396/4885CTSA 2635/4885RAB9A 1317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.